Monthly Archives: October 2018

HSS Receives Landmark $10 Million Grant from Stavros Niarchos Foundation for Complex Joint Reconstruction Center

NEW YORK, Oct. 16, 2018 /PRNewswire/ -- An unprecedented $10 million grant from the Stavros Niarchos Foundation (SNF) has been given to Hospital for Special Surgery (HSS) to name the Complex Joint Reconstruction Center (CJRC). This new commitment will support the endowment of the CJRC for the operation and expansion of its clinical, research and educational programs. According to the

By |2018-10-16T16:21:11+00:00October 16th, 2018|Recon, Top Stories|

TransEnterix to Showcase First Digital Laparoscopic Surgical Platform, the Senhance Surgical System, at American College of Surgeons Clinical Congress 2018

October 16, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced demonstrations of its Senhance™ Surgical System at the American College of Surgeons (ACS) Clinical Congress 2018 at the Boston Convention & Visitors Center

By |2018-10-16T15:20:45+00:00October 16th, 2018|Robotics|

Amplitude Surgical: Mrs. Muriel Benedetto is Appointed to the Newly-Created Position of COO

October 15, 2018 VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (Paris:AMPLI), a leading French player on the global surgical technology market for lower-limb orthopedics, announces the appointment of Mrs. Muriel Benedetto Marmilloud to the newly-created position of Chief Operating Officer (COO). She will report directly to Olivier Jallabert, Chairman and

By |2018-10-15T22:31:05+00:00October 15th, 2018|Extremities|

Zimmer Biomet and Apple Collaborate to Launch Major Clinical Study Detailing Patient Experience and Improving Joint Replacement Journey

WARSAW, Ind., Oct. 15, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, is working with Apple by using Apple Watch and iPhone to change the patient journey for two of the most common surgeries Americans undergo each year – knee and hip replacement. This collaboration has yielded Zimmer Biomet mymobility™, an app that uses Apple Watch to facilitate a new level

By |2018-10-15T17:10:38+00:00October 15th, 2018|Recon|

Xtant Medical Announces Appointment of Interim CEO

BELGRADE, MT, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Michael Mainelli to serve as Interim Chief Executive Officer, replacing Carl O’Connell effective October 12, 2018. Mr. Mainelli joined the

By |2018-10-15T16:50:15+00:00October 15th, 2018|Spine|

Field Orthopaedics Forms Exclusive Partnership With Ortho Consulting Group to Launch New Micro Screw Into EMEA

BASINGSTOKE, England, October 15, 2018 /PRNewswire/ -- Partnering with Ortho Consulting Group, Field Orthopaedics is expanding its market presence for their innovative Micro Screw System in EMEA. The unique 1.5mm screw with a rigid cannulation is designed for small fractures in the hand. New to EMEA market, CE registration pending. Innovators of the Micro Screw System, Australian-based Field Orthopaedics, has signed

By |2018-10-15T16:09:36+00:00October 15th, 2018|Extremities|

TDM USA Enters Domestic Extremity Market, Launches Six Product Systems at OTA

TDM USA, based in Salt Lake City, Utah, is pleased to announce its entry into the rapidly expanding US extremity market with the launch of six new product systems at the 2018 Annual Meeting of the Orthopaedic Trauma Association (OTA) in Kissimmee, Florida from October 17-20. Bringing true value to facilities, surgeons and patients requires

By |2018-10-15T15:13:33+00:00October 15th, 2018|Extremities, Top Stories|

SeaSpine Prices Public Offering of Common Stock

CARLSBAD, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwritten public offering of 3,250,000 shares of its common stock at a public offering price

By |2018-10-11T21:21:35+00:00October 11th, 2018|Financial|

SpinalCyte Announces Publication Supporting the Therapeutic Effects of Fibroblast Cell Therapy in Disc Degeneration and Inflammation in The Spine Journal

HOUSTON, Oct. 11, 2018 /PRNewswire/ -- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts, today announced the publication of results from its study on using cell transplantation as a cell therapy for disc degeneration. The article titled "Therapeutic Effects of Cell Therapy with Neonatal Human Dermal Fibroblasts and

By |2018-10-11T20:54:35+00:00October 11th, 2018|Biologics|

Arthrosurface Launches the Stemless OVOMotion™ Shoulder Arthroplasty System

FRANKLIN, Mass., Oct. 11, 2018 /PRNewswire/ -- Arthrosurface®, Inc. announced today the official launch of its latest product, the stemless OVOMotion™ Shoulder Arthroplasty System with Inlay Glenoid. FDA Cleared in April 2018, this stemless total shoulder system provides the surgeon with an approach that results in increased exposure to the glenoid, minimal bone removal, and is designed for patients

By |2018-10-11T19:08:13+00:00October 11th, 2018|Recon|